Literature DB >> 23584696

Diffuse versus nondiffuse small (≤ 3 MM thickness) choroidal melanoma: comparative analysis in 1,751 cases. The 2012 F. Phinizy Calhoun lecture.

Carol L Shields1, Swathi Kaliki, Minoru Furuta, Jerry A Shields.   

Abstract

OBJECTIVE: To determine prognosis of small choroidal melanoma (≤ 3 mm thickness) comparing diffuse versus nondiffuse variants.
METHODS: Retrospective chart review of 1,751 patients with small choroidal melanoma classified as diffuse (thickness/base ≤ 20%) versus nondiffuse (thickness/base >20%).
RESULTS: Of 1,751 patients with small choroidal melanoma, 297 (17%) were diffuse and 1,454 (83%) nondiffuse. Features with statistical differences (diffuse vs. nondiffuse) included mean distance to optic disk (3 vs. 4 mm), mean tumor base (12 vs. 8 mm), and mean tumor thickness (1.9 vs. 2.5 mm). Using Kaplan-Meier estimates, melanoma-related metastasis (diffuse vs. nondiffuse) was 8% versus 4% at 5 years, 16% versus 10% at 10 years, and 19% versus 16% at 15 years (P = 0.0344). Melanoma-related death was 6% versus 2% at 5 years, 11% versus 4% at 10 years, and 16% versus 6% at 15 years (P < 0.0001). In the subgroup of thin melanoma 2 mm or less in thickness, melanoma-related death was 7% versus 2% at 5 years, 10% versus 2% at 10 years, and 16% versus 4% at 15 years (P = 0.0077). By multivariate analysis, factors predictive of metastasis from diffuse melanoma included larger tumor basal dimension (P = 0.0027) and plateau/flat tumor configuration (P = 0.0257).
CONCLUSION: Of 1751 patients with small (≤ 3 mm thickness) choroidal melanoma, those with diffuse tumor show higher probability of metastasis and death than those with nondiffuse tumor. This finding is evident even in the thinnest melanomas (≤ 2 mm thickness).

Entities:  

Mesh:

Year:  2013        PMID: 23584696     DOI: 10.1097/IAE.0b013e318285cd52

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  5 in total

1.  Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy.

Authors:  Carol L Shields; Kareem Sioufi; Archana Srinivasan; Maura Di Nicola; Babak Masoomian; Laura E Barna; Vladislav P Bekerman; Emil A T Say; Arman Mashayekhi; Jacqueline Emrich; Lydia Komarnicky; Jerry A Shields
Journal:  JAMA Ophthalmol       Date:  2018-12-01       Impact factor: 7.389

Review 2.  Ocular melanoma: an overview of the current status.

Authors:  Predrag Jovanovic; Marija Mihajlovic; Jasmina Djordjevic-Jocic; Slobodan Vlajkovic; Sonja Cekic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

Review 3.  Using risk factors for detection and prognostication of uveal melanoma.

Authors:  Pukhraj Rishi; Vikram V Koundanya; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

Review 4.  Uveal melanoma: estimating prognosis.

Authors:  Swathi Kaliki; Carol L Shields; Jerry A Shields
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

5.  Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques

Authors:  Asma Belaïd; Chiraz Nasr; Omar Jmour; Aziz Cherif; Lotfi Kochbati; Hedi Bouguila; Mounir Besbes; Farouk Benna
Journal:  Asian Pac J Cancer Prev       Date:  2016-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.